189.51
Ishares Biotechnology Etf stock is traded at $189.51, with a volume of 893.17K.
It is up +0.26% in the last 24 hours and up +4.38% over the past month.
See More
Previous Close:
$188.98
Open:
$189.97
24h Volume:
893.17K
Relative Volume:
0.59
Market Cap:
$9.09B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.15%
1M Performance:
+4.38%
6M Performance:
+8.07%
1Y Performance:
+39.91%
Ishares Biotechnology Etf Stock (IBB) Company Profile
Name
Ishares Biotechnology Etf
Sector
Industry
Phone
-
Address
-
Compare IBB vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
IBB
Ishares Biotechnology Etf
|
189.50 | 9.09B | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
367.19 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
743.48 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
746.96 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
297.10 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
691.62 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Biotechnology Etf Stock (IBB) Latest News
iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026? - The Motley Fool
Which iShares Healthcare ETF Is the Better Buy: Diversified IXJ or Biotech-Focused IBB? - The Motley Fool
iShares Biotechnology ETF (rIBB) Price Prediction - Bitget
Is the iShares Healthcare ETF or the Invesco Nasdaq Biotech ETF the Better Bet for Investors in 2026? - The Motley Fool
Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT? - The Motley Fool
IXJ vs. IBBQ: Global Healthcare vs. Biotech -- Which ETF Is the Better Buy? - The Globe and Mail
Understanding the Shape of the iShares Biotechnology ETF Portfolio - sekbernews.id
IBB ETF Holds Fewer Bets Than You Think - Trefis
$188.977 | iShares Biotechnology ETF (IBB) Stock Price Today - Binance
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance? - AOL.com
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance? - The Motley Fool
Healthcare ETFs Face-Off: Stability vs. Biotech Growth, Which Strategy Wins? - finance.biggo.com
5 Best Biotech ETFs for 2026 and How to Invest - The Motley Fool
IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy? - The Motley Fool
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance
iShares NASDAQ Biotechnology ETF declares quarterly distribution of $0.0238 - MSN
Cramer’s mad dash: iShares Biotechnology ETF - MSN
iShares Biotechnology ETF(IBB) Stock Options Chain | Quotes & News - Moomoo
Cramer’s Mad Dash: iShares Biotechnology ETF - CNBC
Vanguard Health Care vs. iShares Biotech: How Do These ETFs Stack Up? - The Motley Fool
IBBiShares Biotechnology ETF Dividends - Finviz
RXRX rallies past biotech ETFs as short interest, insider-sale filings shape coming week - TechStock²
SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns - The Motley Fool
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Yahoo Finance
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - Yahoo Finance
Healthcare Stocks Got A Late Lift From Big Headlines - Finimize
Greece’s Return and a Chip Meltdown: MSCI World ETF Caught Between Index History and Market Chaos - Ad-hoc-news.de
How Ishares Biotechnology Etf (IBB) Affects Rotational Strategy Timing - Stock Traders Daily
The biotech sector looks ready for a multi-year breakout: Here's what to watch - MSN
The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch. - MarketBeat
Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A - ETF Database
Biotech's Silent Resurgence (5-Year Base Breakout) - TradingView
Biotech breakout: iShares Biotechnology ETF hits all-time high - Seeking Alpha
Why Is Natera Stock Gaining Tuesday? - Benzinga
Biotech ETFs Put Up Strong Show in 1H 2026: More Gains Ahead? - TradingView
Biotech ETF hits record as AbbVie seals $10.9B Apogee deal - MSN
Sector Update: Healthcare - Moomoo
As AbbVie eyes Apogee, these biotech stocks earn the highest Quant ratings (IBB:NASDAQ) - Seeking Alpha
DFTX Stock Rallies Ahead Of High-Stakes Phase 3 Depression Drug Trial Results — What Investors Need To Know - TradingView
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
Syntax Bio expands Series A to $14.4M, adds leadership and board members (IBB:NASDAQ) - Seeking Alpha
2Seventy Bio Inc (TSVT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CARGO Therapeutics Inc (CRGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biomea Fusion Inc (BMEA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CureVac NV (CVAC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ishares Biotechnology Etf Stock (IBB) Financials Data
There is no financial data for Ishares Biotechnology Etf (IBB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):